ITCI
Intra-Cellular Therapies Inc
Price:  
80.39 
USD
Volume:  
625,486.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ITCI WACC - Weighted Average Cost of Capital

The WACC of Intra-Cellular Therapies Inc (ITCI) is 7.3%.

The Cost of Equity of Intra-Cellular Therapies Inc (ITCI) is 10.95%.
The Cost of Debt of Intra-Cellular Therapies Inc (ITCI) is 5.00%.

Range Selected
Cost of equity 7.50% - 14.40% 10.95%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.6% - 9.0% 7.3%
WACC

ITCI WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.78 1.7
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.50% 14.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.6% 9.0%
Selected WACC 7.3%